Obesity and T2D drugs drive Novo Nordisk and Eli Lilly Q2 2023 growth
The market cap for both companies will continue to grow in line with the increasing growth projections for Lilly’s Mounjaro and Novo’s Wegovy and Ozempic.
Global Healthcare and Pharma Market Outlook
Risk sharing agreements soar as market access risk increases
Inflationary storm clouds will continue to buffet global pharma industry in 2023
Inflation, drug pricing and reimbursement constraints will challenge pharma sector
The top ten pharma companies best positioned to weather future industry disruption
BioMarin’s Voxzogo obtains Japan’s MHLW approval for achondroplasia
Longevity technology and its future
Takeda to transfer marketing authorisation for Spikevax in Japan to Moderna
